Cargando…

Assessment of Insulin Therapy as a Risk Factor for Hirsutism Among Diabetic Females in Saudi Arabia

Introduction Hirsutism is defined as a condition in which women develop excessive body hair in androgen-dependent areas, which include lips, chin, chest, abdomen, back, and femoral region. The link between hyperandrogenism and insulin resistance and/or hyperinsulinemia is well established. Polycysti...

Descripción completa

Detalles Bibliográficos
Autores principales: Alghanim, Abdullah J, Alfalah, Faisal M, Al Zaid, Ali R, AlRamadan, Mohammed, Alhuwayji, Khalid A, Alnasser, Hussain M, Alamer, Ali T, Albahrani, Suha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838245/
https://www.ncbi.nlm.nih.gov/pubmed/36654645
http://dx.doi.org/10.7759/cureus.32512
_version_ 1784869240048713728
author Alghanim, Abdullah J
Alfalah, Faisal M
Al Zaid, Ali R
AlRamadan, Mohammed
Alhuwayji, Khalid A
Alnasser, Hussain M
Alamer, Ali T
Albahrani, Suha
author_facet Alghanim, Abdullah J
Alfalah, Faisal M
Al Zaid, Ali R
AlRamadan, Mohammed
Alhuwayji, Khalid A
Alnasser, Hussain M
Alamer, Ali T
Albahrani, Suha
author_sort Alghanim, Abdullah J
collection PubMed
description Introduction Hirsutism is defined as a condition in which women develop excessive body hair in androgen-dependent areas, which include lips, chin, chest, abdomen, back, and femoral region. The link between hyperandrogenism and insulin resistance and/or hyperinsulinemia is well established. Polycystic ovary syndrome, as a form of hyperandrogenism, has been linked to several diseases, including type 2 diabetes mellitus and hirsutism. However, it is unknown how common hyperandrogenic problems are in women who receive exogenous insulin. Therefore, this study aims to assess the effect of insulin intake and other sociodemographic factors on the development of hirsutism among diabetic females. Methods This case-control study was conducted in six regions of Saudi Arabia, including Al-Ahsa, Dammam, Qatif, Riyadh, Abha, and Jeddah, during the year 2022. The population was Saudi females who were diabetic, between the age of 18 and 65 years, and living in Saudi Arabia. The sample size was 186 participants. Of the participants, 48 had considerable hirsutism whereas 138 did not. The degree of hirsutism has been determined using the Ferriman and Gallwey scoring tool. Results A total of 186 diabetic females were included in the study. Among the females, 97 (52.2%) were on insulin therapy and 89 (47.8%) were on non-insulin therapies. Only hair distribution on the chin showed a significant difference between the study groups where 4.1% of cases on insulin showed complete cover with light or heavy hair on the chin compared to 3.4% of controls (P = 0.049). There was no significant difference regarding hirsutism score among the study patients according to insulin intake where the mean score was 5.4 ± 5.1 among cases on insulin versus 4.7 ± 5.1 for controls (P = 0.978). Adjusted logistic regression models showed an insignificant association between diabetic female hirsutism and insulin intake (OR = 1.1 and 1.0, respectively; P > 0.05). Conclusion Many factors were examined to reveal their associations with hirsutism in diabetic females. Neither the type of diabetes nor insulin intake was significantly correlated with the development of hirsutism. On the other hand, age was found to be significantly associated with the development of hirsutism among age groups (<30, 30-49, and 50+; P = 0.49). It seemed that the prevalence of hirsutism decreases as age advances.
format Online
Article
Text
id pubmed-9838245
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-98382452023-01-17 Assessment of Insulin Therapy as a Risk Factor for Hirsutism Among Diabetic Females in Saudi Arabia Alghanim, Abdullah J Alfalah, Faisal M Al Zaid, Ali R AlRamadan, Mohammed Alhuwayji, Khalid A Alnasser, Hussain M Alamer, Ali T Albahrani, Suha Cureus Dermatology Introduction Hirsutism is defined as a condition in which women develop excessive body hair in androgen-dependent areas, which include lips, chin, chest, abdomen, back, and femoral region. The link between hyperandrogenism and insulin resistance and/or hyperinsulinemia is well established. Polycystic ovary syndrome, as a form of hyperandrogenism, has been linked to several diseases, including type 2 diabetes mellitus and hirsutism. However, it is unknown how common hyperandrogenic problems are in women who receive exogenous insulin. Therefore, this study aims to assess the effect of insulin intake and other sociodemographic factors on the development of hirsutism among diabetic females. Methods This case-control study was conducted in six regions of Saudi Arabia, including Al-Ahsa, Dammam, Qatif, Riyadh, Abha, and Jeddah, during the year 2022. The population was Saudi females who were diabetic, between the age of 18 and 65 years, and living in Saudi Arabia. The sample size was 186 participants. Of the participants, 48 had considerable hirsutism whereas 138 did not. The degree of hirsutism has been determined using the Ferriman and Gallwey scoring tool. Results A total of 186 diabetic females were included in the study. Among the females, 97 (52.2%) were on insulin therapy and 89 (47.8%) were on non-insulin therapies. Only hair distribution on the chin showed a significant difference between the study groups where 4.1% of cases on insulin showed complete cover with light or heavy hair on the chin compared to 3.4% of controls (P = 0.049). There was no significant difference regarding hirsutism score among the study patients according to insulin intake where the mean score was 5.4 ± 5.1 among cases on insulin versus 4.7 ± 5.1 for controls (P = 0.978). Adjusted logistic regression models showed an insignificant association between diabetic female hirsutism and insulin intake (OR = 1.1 and 1.0, respectively; P > 0.05). Conclusion Many factors were examined to reveal their associations with hirsutism in diabetic females. Neither the type of diabetes nor insulin intake was significantly correlated with the development of hirsutism. On the other hand, age was found to be significantly associated with the development of hirsutism among age groups (<30, 30-49, and 50+; P = 0.49). It seemed that the prevalence of hirsutism decreases as age advances. Cureus 2022-12-14 /pmc/articles/PMC9838245/ /pubmed/36654645 http://dx.doi.org/10.7759/cureus.32512 Text en Copyright © 2022, Alghanim et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Alghanim, Abdullah J
Alfalah, Faisal M
Al Zaid, Ali R
AlRamadan, Mohammed
Alhuwayji, Khalid A
Alnasser, Hussain M
Alamer, Ali T
Albahrani, Suha
Assessment of Insulin Therapy as a Risk Factor for Hirsutism Among Diabetic Females in Saudi Arabia
title Assessment of Insulin Therapy as a Risk Factor for Hirsutism Among Diabetic Females in Saudi Arabia
title_full Assessment of Insulin Therapy as a Risk Factor for Hirsutism Among Diabetic Females in Saudi Arabia
title_fullStr Assessment of Insulin Therapy as a Risk Factor for Hirsutism Among Diabetic Females in Saudi Arabia
title_full_unstemmed Assessment of Insulin Therapy as a Risk Factor for Hirsutism Among Diabetic Females in Saudi Arabia
title_short Assessment of Insulin Therapy as a Risk Factor for Hirsutism Among Diabetic Females in Saudi Arabia
title_sort assessment of insulin therapy as a risk factor for hirsutism among diabetic females in saudi arabia
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9838245/
https://www.ncbi.nlm.nih.gov/pubmed/36654645
http://dx.doi.org/10.7759/cureus.32512
work_keys_str_mv AT alghanimabdullahj assessmentofinsulintherapyasariskfactorforhirsutismamongdiabeticfemalesinsaudiarabia
AT alfalahfaisalm assessmentofinsulintherapyasariskfactorforhirsutismamongdiabeticfemalesinsaudiarabia
AT alzaidalir assessmentofinsulintherapyasariskfactorforhirsutismamongdiabeticfemalesinsaudiarabia
AT alramadanmohammed assessmentofinsulintherapyasariskfactorforhirsutismamongdiabeticfemalesinsaudiarabia
AT alhuwayjikhalida assessmentofinsulintherapyasariskfactorforhirsutismamongdiabeticfemalesinsaudiarabia
AT alnasserhussainm assessmentofinsulintherapyasariskfactorforhirsutismamongdiabeticfemalesinsaudiarabia
AT alameralit assessmentofinsulintherapyasariskfactorforhirsutismamongdiabeticfemalesinsaudiarabia
AT albahranisuha assessmentofinsulintherapyasariskfactorforhirsutismamongdiabeticfemalesinsaudiarabia